SCN5A and Arrhythmia: Altogether, these data indicate that ajmaline consistently lengthens the activation-recovery interval as well as slightly reducing activation in hPSC cardiac clusters, however hPSC clusters from BrS patients absent of SCN5A arrhythmia-associated rare variants are neither more nor less sensitive to these effects compared to control.